华润置地(01109)发布公告，截至20261月31日止1个月，公司及其附属公司实现总合同销售额约人民币 116.5亿元，总合同销售建筑面积约36.8万平方米，分别按年增长0.4%及减少24.6%。 20261月，集团经常性收入约人民币45.1亿元，按年增长8.7%，其中，经营性不动产业务租金收入约人 民币31.1亿元，按年增长13.7%。 ...

Core Viewpoint - LeMo Technology (02539) has announced a joint venture agreement with Shanghai Cat One Meeting to establish a joint entity focused on providing machine massage services in office spaces [1] Group 1: Joint Venture Details - The joint venture will involve an investment of RMB 8 million from LeMo Technology and RMB 2 million from Shanghai Cat One Meeting, representing 80% and 20% of the registered capital respectively [1] - The newly formed entity will become a non-wholly owned subsidiary of LeMo Technology [1] Group 2: Strategic Intent - The company is actively exploring new market opportunities in the massage service sector and aims to leverage the expertise of its Executive Director and Technical Director, Mr. Chen Xing, in core massage chair technology, IoT platforms, and operating systems [1] - The establishment of the joint venture is intended to create synergies in product development and market expansion, particularly in the customized technology adjustments and precision operations required for mechanical massage services in office environments [1] - The agreement aligns Mr. Chen's incentives with the success of the joint venture, ensuring his full commitment to contributing to the overall performance of the group [1]

公司董事会主席兼总裁白鹏博士对2025年第四季度及全年业绩评论道："华虹半导体2025年第四季度销 售收入再创历史新高，达6.599亿美元，单季度毛利率为13.0%，均符合指引预期。2025年全年，公司实 现销售收入24.021亿美元，毛利率为11.8%，同比均实现增长并符合管理层预期。在全球半导体市场受 AI及其相关产品需求拉动、国内消费类需求回暖的背景下，公司产能维持高位运行，全年平均产能利 用率为106.1%，处于晶圆代工企业领先水準。" 白总继续表示："通过优化产品组合及降本增效，公司各特色工艺平台均表现强劲，尤其是独立式闪存 和电源管理平台，有力支撑了公司业绩增长与利润率上升。2025年度，公司继续推进扩大产能的战略规 划，无锡第二条12英寸产线(FAB9)一阶段产能建设超预期完成，上海12英寸制造基地(FAB5)收购事项 有序推进。展望未来，公司将通过创新和快速迭代，持续高度聚焦于打造世界级特色工艺技术平台，并 深化与国内外战略客户的合作。我们有信心在全球半导体产业变局中把握增长机遇，力争达到股东的长 期期许。" 此外，预计2026年第一季度销售收入约在6.5亿美元至6.6亿美元之间，预计毛利率约 ...

吉利汽车(00175)发布公告，于2026年2月12日，该公司斥资2792.75万港元回购165.6万股。 ...

鼎立资本(00356)发布公告，于2026年1月31日，公司每股股份的未经审核综合资产净值约为0.024港元。 ...

芯化兰德(08106)发布公告，本公司H股已自2026年2月12日上午九时正起于香港联合交易所有限公司 GEM暂停买卖，以待有关本公司日期为2026年2月11日内容有关根据一般授权认购新H股的公告的补充 资料公布。 ...

Core Viewpoint - BOSS Zhipin (02076) announced a plan to purchase a total of 329,530 Class A ordinary shares, equivalent to 164,800 American Depositary Shares, through internal resources on February 11, 2026 [1] Group 1 - The company will utilize internal resources to fund the share purchase [1] - The shares will be held in trust for eligible participants [1] - The purchase will occur in the open market according to the terms and conditions of the plan [1]

Group 1 - The company, Liwa Holdings Group (01346), announced a final dividend of HKD 0.07 per share to be distributed on April 24, 2026 [1]

2025年股东应占溢利下跌的主要原因是亚太地区的卫星转发器资源供过于求的状况仍在持续，市场竞争 激烈导致价格下降，进而对营业收入造成负面影响;及转租成本上升。 亚太卫星(01045)发布公告，本集团预期截至2025年12月31日止财务年度的股东应占溢利较去年同期下 跌约31%。 同时，本集团已开展下一代新型卫星的研制准备，以提高集团后续卫星资源的先进性和竞争力。 尽管面临外部环境的挑战，本集团财务状况稳健、资金充裕，后续将利用集团及联营公司卫星及地面网 络资源，加强核心市场开发以及本地化业务经营，以提升集团的服务能力并保持盈利。 ...

Group 1 - The core viewpoint of the article is that China Biologic Products (01177) has completed the enrollment of subjects for the Phase III clinical trials of two drugs, TQB2102 and LM302 [1] - LM302 is noted as the world's first CLDN18.2 antibody drug complex to complete subject enrollment in Phase III registration clinical trials, potentially providing new treatment options for patients [1] - Bank of America Securities has set a target price of HKD 8.6 and reiterated a "Buy" rating for the company [1]